• Castle Biosciences (CSTL) to Release Q2 Financial Results on Jul GuruFocus Thu, 09 Jul 2026 14:18:05 GMT
• Castle Biosciences to Release Second Quarter 2026 Financial Results and Host Webcast on Thursday, July 30, 2026 Yahoo Finance Thu, 09 Jul 2026 11:00:00 GMT
• Castle Biosciences updates its melanoma testing strategy as diagnostics demand grows AD HOC NEWS Wed, 08 Jul 2026 17:34:25 GMT
• Castle Biosciences (CSTL) COO sells 8,586 shares under 10b5-1 plan Stock Titan Mon, 06 Jul 2026 21:04:10 GMT
• Derek Maetzold, pres. & CEO, sells $238,916 of Castle Biosciences stock Investing.com Mon, 06 Jul 2026 20:37:39 GMT
• Form 4 Castle Biosciences Inc For: 6 July By Investing.com Investing.com Canada Mon, 06 Jul 2026 20:35:25 GMT
• Castle Biosciences (CSTL) CEO sells 9,836 shares via 10b5-1 plan Stock Titan Mon, 06 Jul 2026 20:25:58 GMT
• The Technical Signals Behind (CSTL) That Institutions Follow Stock Traders Daily Mon, 06 Jul 2026 16:10:02 GMT
• Enterprise value to revenue forward of Castle Biosciences, Inc. – NASDAQ:CSTL TradingView Sat, 04 Jul 2026 12:17:11 GMT
• Castle Biosciences Inc (CSTL) Stock Forecast, Price Targets and Analysts Predictions GuruFocus Fri, 03 Jul 2026 00:01:09 GMT
• Form 144 Castle Biosciences For: 1 July By Investing.com Investing.com Canada Wed, 01 Jul 2026 21:52:08 GMT
• Maetzold family Rule 144 sales reported for CSTL (CSTL) — multiple small lots Stock Titan Wed, 01 Jul 2026 07:00:00 GMT
• Castle Biosciences (CSTL) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Stock Higher - Slow Growth Warning dars.gov.et Sun, 28 Jun 2026 07:00:00 GMT
• Castle Biosciences (CSTL) Surges 6% as Bullish Momentum Builds - Merger Arbitrage dars.gov.et Sat, 27 Jun 2026 07:00:00 GMT
• castle biosciences (cstl) stock sees split analyst revisions as price targets come down Yahoo Finance Fri, 26 Jun 2026 10:07:38 GMT
• castle biosciences (cstl) study highlights advancements in melan GuruFocus Fri, 26 Jun 2026 07:06:28 GMT
• Castle Biosciences updates its melanoma test data, shares in biotech focus AD HOC NEWS Fri, 26 Jun 2026 07:00:00 GMT
• castle biosciences inc (cstl) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 26 Jun 2026 07:00:00 GMT
• castle biosciences, inc. actuals & estimates (nasdaq:cstl) TradingView Fri, 26 Jun 2026 06:27:03 GMT
• Castle Biosciences’ melanoma test outperforms risk tool By Investing.com Investing.com South Africa Fri, 26 Jun 2026 02:33:07 GMT
• lake street maintains castle biosciences(cstl.us) with buy rating, maintains target price $52 富途牛牛 Fri, 26 Jun 2026 01:10:38 GMT
• castle biosciences, inc. actuals & estimates (tradegate:086) TradingView Fri, 26 Jun 2026 00:08:21 GMT
• castle biosciences (cstl) study highlights advancements in melan GuruFocus Thu, 25 Jun 2026 21:33:56 GMT
• Castle Biosciences’ melanoma test outperforms risk tool By Investing.com Investing.com Canada Thu, 25 Jun 2026 20:45:45 GMT
• enterprise value to ebit forward of castle biosciences, inc. – nasdaq:cstl TradingView Thu, 25 Jun 2026 20:36:43 GMT
• DecisionDx®-Melanoma's i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy yankton.net Thu, 25 Jun 2026 20:30:00 GMT
• Precision Trading with Castle Biosciences Inc. (CSTL) Risk Zones Stock Traders Daily Thu, 25 Jun 2026 15:02:02 GMT
• Castle Biosciences test better spots melanoma patients who may skip surgery Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• CSTL Initiated by Roth Capital -- Price Target Announced at $40. GuruFocus Thu, 25 Jun 2026 07:00:00 GMT
• enterprise value to ebitda forward of castle biosciences, inc. – nasdaq:cstl TradingView Thu, 25 Jun 2026 05:37:18 GMT
• enterprise value to revenue forward of castle biosciences, inc. – tradegate:086 TradingView Thu, 25 Jun 2026 05:17:34 GMT
• castle biosciences (cstl) receives buy rating and $40 target fro GuruFocus Thu, 25 Jun 2026 05:11:23 GMT
• castle biosciences inc (cstl) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• castle biosciences inc (cstl) valuation: pe, pb & fair value analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• Castle Biosciences CFO Frank Stokes named among 22 Houston finance leaders Stock Titan Tue, 23 Jun 2026 11:06:40 GMT
• Castle Biosciences' Chief Financial Officer Frank Stokes Named a 2026 CFO Awards Honoree by the Houston Business Journal Nasdaq Tue, 23 Jun 2026 11:00:00 GMT
• Castle Biosciences CFO Frank Stokes Named Houston Business Journal CFO Awards Honoree citybiz Tue, 23 Jun 2026 07:00:00 GMT
• Castle Biosciences CFO receives Houston business award Investing.com Tue, 23 Jun 2026 07:00:00 GMT
• CSTL Q1 2026 Earnings: Narrowly Exceeds EPS Estimates, Stock Edges Higher - Retail Earnings Report dars.gov.et Tue, 23 Jun 2026 07:00:00 GMT
• Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire Fri, 19 Jun 2026 07:00:00 GMT
• Castle Biosciences (CSTL) COO sells 8,587 shares, retains over 127K Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• castle biosciences inc (cstl) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 06:10:38 GMT
• Castle Biosciences Inc (CSTL) Valuation: PE, PB & Fair Value Analysis TradingKey Thu, 18 Jun 2026 05:50:32 GMT
• castle biosciences inc (cstl) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 05:27:07 GMT
• castle biosciences inc (cstl) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 05:25:14 GMT
• castle biosciences inc (cstl) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 03:22:49 GMT
• Castle Biosciences president & CEO Derek J. Maetzold sells $86,193 stock Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• Castle Biosciences (CSTL) CEO Maetzold exercises options, trusts sell 4,172 shares Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• castle biosciences (cstl) surpasses 100,000 tissuecypher test or GuruFocus Tue, 16 Jun 2026 18:24:53 GMT
• Castle Biosciences' TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett's E... Yahoo Finance Tue, 16 Jun 2026 07:00:00 GMT
• CSTL (NASDAQ) Rule 144 notice: director sale notice for 4,152 shares Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Castle Biosciences’ Barrett’s esophagus test reaches 100k orders By Investing.com Investing.com Canada Tue, 16 Jun 2026 07:00:00 GMT
• castle biosciences stock (us14843c1053): q1 beat, guidance in focus after recent pullback AD HOC NEWS Tue, 09 Jun 2026 18:23:26 GMT
• how the castle biosciences (cstl) investment story is evolving without fresh analyst commentary Yahoo Finance Tue, 09 Jun 2026 07:00:00 GMT
• Castle Biosciences (CSTL) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Cautious Investor Response dars.gov.et Mon, 08 Jun 2026 07:00:00 GMT
• earnings call transcript: castle biosciences q1 2026 sees revenue growth Investing.com Fri, 05 Jun 2026 13:01:52 GMT
• castle biosciences q1 2026 slides: revenue beats, guidance raised Investing.com Fri, 05 Jun 2026 13:01:52 GMT
• cstl: raised 2026 guidance after strong q1 growth and expanded diagnostic test adoption TradingView Wed, 03 Jun 2026 19:10:01 GMT
• trading the move, not the narrative: (cstl) edition Stock Traders Daily Wed, 03 Jun 2026 12:20:01 GMT
• castle biosciences (cstl) ceo sells shares and exercises options under 10b5-1 plan Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• Castle Biosciences Q1 2026 Earnings: EPS Beats Estimates Amid Absent Revenue Data and Stock Dip - Analyst Consensus Shift dars.gov.et Tue, 02 Jun 2026 07:00:00 GMT
• Director at Castle Biosciences (CSTL) awarded 11,766 restricted stock units Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• Maetzold-related trusts sell shares (CSTL) in multiple Form 144 trades Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• castle biosciences (cstl) director receives 11,766 rsus in new equity grant Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• castle biosciences (nasdaq: cstl) grants 11,766 rsus to director Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• castle biosciences stock (us14843c1053): shares steady after recent q1 2024 update AD HOC NEWS Mon, 01 Jun 2026 07:00:00 GMT
• director at castle biosciences (cstl) receives 11,766 rsu equity award Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• director at castle biosciences (cstl) granted 11,766 rsus Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• is castle biosciences inc (cstl) a bargain after 4.7% drop? gf v GuruFocus Sat, 30 May 2026 01:00:49 GMT
• castle biosciences (nasdaq: cstl) investors approve directors, pay and kpmg Stock Titan Fri, 29 May 2026 07:00:00 GMT
• castle biosciences stock (us14843c1053): shares trade steady as nasdaq investors eye valuation ahead AD HOC NEWS Fri, 29 May 2026 07:00:00 GMT
• is castle biosciences inc (cstl) a bargain after 4.7% drop? gf v GuruFocus Fri, 29 May 2026 07:00:00 GMT
• castle biosciences (nasdaq:cstl) downgraded by zacks research to "hold" MarketBeat Thu, 28 May 2026 09:51:24 GMT
• wall street analysts predict an 85.15% upside in castle biosciences (cstl): here's what you should know MSN Thu, 28 May 2026 01:37:17 GMT
• director daniel bradbury adds 13,667 cstl shares via rsu exercise, boosts direct and trust holdings Stock Titan Wed, 27 May 2026 20:18:47 GMT
• castle biosciences (cstl) director converts 13,667 rsus into common stock Stock Titan Wed, 27 May 2026 07:00:00 GMT
• castle biosciences (cstl) director receives 13,667 shares via rsus Stock Titan Wed, 27 May 2026 07:00:00 GMT
• director at castle biosciences (cstl) gains 13,667 shares via rsu exercise Stock Titan Wed, 27 May 2026 07:00:00 GMT
• director at castle biosciences (cstl) settles 13,667 rsus into common stock Stock Titan Wed, 27 May 2026 07:00:00 GMT
• director at castle biosciences (nasdaq: cstl) converts 13,667 rsus to shares Stock Titan Wed, 27 May 2026 07:00:00 GMT
• castle biosciences’ advancead-tx™ test wins 2026 medtech breakthrough award for genomics innovation geneonline.com Tue, 26 May 2026 20:24:14 GMT
• castle biosciences (cstl) cco exercises options to add 11,210 shares Stock Titan Tue, 26 May 2026 07:00:00 GMT
• How The Castle Biosciences (CSTL) Story Is Shifting After Solid Q1 And Lower Targets Yahoo Finance Sun, 24 May 2026 07:00:00 GMT
• castle biosciences (cstl) ceo reports planned stock sales and option exercises Stock Titan Fri, 22 May 2026 20:12:30 GMT
• castle biosciences, inc. - common stock (nq: cstl The Chronicle-Journal Fri, 22 May 2026 20:00:01 GMT
• castle biosciences (cstl) is on the move, here's why the trend could be sustainable MSN Thu, 21 May 2026 09:06:23 GMT
• castle biosciences, inc. $cstl shares sold by ubs group ag MarketBeat Thu, 21 May 2026 08:07:52 GMT
• castle biosciences stock (us14843c1053): fresh earnings data keeps diagnostics specialist in focus AD HOC NEWS Tue, 19 May 2026 07:00:00 GMT
• rtw funds own 2.76m castle biosciences shares (cstl) — 9.3% stake Stock Titan Fri, 15 May 2026 07:00:00 GMT
• portolan capital amends castle biosciences (nasdaq: cstl) 13g; 4.45% stake reported Stock Titan Fri, 15 May 2026 07:00:00 GMT
• a look at castle biosciences inc (cstl) after 4.1% gain -- gf va GuruFocus Fri, 15 May 2026 01:40:36 GMT
• castle biosciences price target lowered to $40 from $50 at btig TipRanks Thu, 14 May 2026 09:00:00 GMT
• a look at castle biosciences inc (cstl) after 4.1% gain -- gf va GuruFocus Thu, 14 May 2026 07:00:00 GMT
• castle biosciences, inc. (cstl) latest stock news & headlines Yahoo Finance Wed, 13 May 2026 20:42:24 GMT
• castle biosciences price target lowered to $40 from $50 at btig TipRanks Wed, 13 May 2026 16:22:15 GMT
• castle biosciences: buy reiterated on strong q1 execution and undervalued growth potential despite price target trim to $40 TipRanks Wed, 13 May 2026 15:55:07 GMT
• Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference PR Newswire Wed, 13 May 2026 07:00:00 GMT
• btig lowers castle biosciences stock price target on higher costs Investing.com Wed, 13 May 2026 07:00:00 GMT
• btig maintains castle biosciences(cstl.us) with buy rating, cuts target price to $40 Moomoo Wed, 13 May 2026 07:00:00 GMT
• castle biosciences, inc. 2026 q1 - results - earnings call presentation (nasdaq:cstl) 2026-05-13 Seeking Alpha Wed, 13 May 2026 07:00:00 GMT
• btig research has lowered expectations for castle biosciences (nasdaq:cstl) stock price MarketBeat Wed, 13 May 2026 07:00:00 GMT
• castle biosciences' advancead-tx™ test receives 2026 medtech bre GuruFocus Wed, 13 May 2026 00:30:23 GMT
• castle biosciences recognized for driving progress in global healthcare with advancead-tx accolade Traders Union Wed, 13 May 2026 00:07:19 GMT
• castle biosciences, inc. (cstl) latest stock news & headlines Yahoo Finance Tue, 12 May 2026 11:47:49 GMT
• test reading 487 genes helps match atopic dermatitis drugs, earns medtech award Stock Titan Tue, 12 May 2026 11:00:00 GMT
• Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation PR Newswire Tue, 12 May 2026 07:00:00 GMT
• price-driven insight from (cstl) for rule-based strategy Stock Traders Daily Tue, 12 May 2026 07:00:00 GMT
• derek maetzold, castle biosciences ceo, sells $217,904 in shares Investing.com Mon, 11 May 2026 07:00:00 GMT
• castle biosciences (cstl) ceo sells shares and exercises stock options in pre-planned trades Stock Titan Mon, 11 May 2026 07:00:00 GMT
• castle biosciences (nasdaq:cstl) cut to "sell" at wall street zen MarketBeat Sat, 09 May 2026 06:45:27 GMT
• castle biosciences, inc. (cstl) stock analysis: a promising 145.58% upside potential DirectorsTalk Interviews Fri, 08 May 2026 09:17:31 GMT
• Castle Biosciences (CSTL) Q1 Loss Of US$14.5 Million Tests Profitability Narrative simplywall.st Fri, 08 May 2026 07:00:00 GMT
• wall street analysts predict an 85.15% upside in castle biosciences (cstl): here's what you should know MSN Thu, 07 May 2026 22:10:58 GMT
• ccorf maintains castle biosciences(cstl.us) with buy rating, maintains target price $40 Moomoo Thu, 07 May 2026 14:31:00 GMT
• castle biosciences q1 2026 slides: revenue beats, guidance raised by investing.com Investing.com Australia Thu, 07 May 2026 12:38:54 GMT
• castle biosciences targets $345m-$355m 2026 revenue as tissuecypher volumes grow 58% and advancead-tx reaches ~650 orders MSN Thu, 07 May 2026 09:48:06 GMT
• Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $43 Moomoo Thu, 07 May 2026 07:00:00 GMT
• lake street maintains castle biosciences(cstl.us) with buy rating, maintains target price $52 富途牛牛 Thu, 07 May 2026 07:00:00 GMT
• derek maetzold files form 144 to sell cstl (nasdaq: cstl) shares Stock Titan Thu, 07 May 2026 07:00:00 GMT
• castle biosciences (nasdaq:cstl) price target lowered to $43.00 at robert w. baird MarketBeat Thu, 07 May 2026 07:00:00 GMT
• castle biosciences down over 15%, on pace for largest percent decrease since july 2024 -- data talk Moomoo Thu, 07 May 2026 07:00:00 GMT
• castle biosciences, inc. (nasdaq:cstl) q1 2026 earnings call transcript Insider Monkey Thu, 07 May 2026 07:00:00 GMT
• castle biosciences (nasdaq:cstl) shares gap down following analyst downgrade MarketBeat Thu, 07 May 2026 07:00:00 GMT
• castle biosciences: buy rating reiterated as strong q1, raised 2026 outlook and unchanged $40 price target underscore undervaluati... TipRanks Thu, 07 May 2026 07:00:00 GMT
• castle biosciences (nasdaq:cstl) releases earnings results, hits expectations MarketBeat Thu, 07 May 2026 01:51:59 GMT
• castle biosciences, inc. q1 2026 earnings call summary Yahoo Finance Thu, 07 May 2026 00:22:00 GMT
• cstl: strong q1 2026 results with raised guidance, record test volumes, and improved financials TradingView Wed, 06 May 2026 22:51:23 GMT
• castle biosciences posts strong q1 results, raises 2026 guidance TipRanks Wed, 06 May 2026 21:07:30 GMT
• earnings flash (cstl) castle biosciences, inc. reports q1 revenue $83.7m, vs. factset est of $79.2m marketscreener.com Wed, 06 May 2026 20:49:35 GMT
• Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates Yahoo Finance Wed, 06 May 2026 07:00:00 GMT
• Castle Biosciences, Inc. Q1 2026 Earnings Call Summary Yahoo Finance Wed, 06 May 2026 07:00:00 GMT
• Earnings call transcript: Castle Biosciences Q1 2026 sees revenue growth Investing.com Wed, 06 May 2026 07:00:00 GMT
Castle Biosciences, Inc(NASDAQ:CSTL) 
Castle Biosciences, Inc., a commercial-stage dermatological cancer company, focuses to provide diagnostic and prognostic solutions for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify high-risk patients with stage I and II melano...
Website: http://www.castlebiosciences.com
Founded: 2007
IPO Price: $16 (Jul 25, 2019)
Full Time Employees: 133
CEO: Derek J. Maetzold
Sector: Healthcare
Industry: Diagnostics & Research